Coming every Saturday, Hodler’s Digest will help you track every single important news story that happened this week. The best (and worst) quotes, adoption and
Read more
Tag: risks
Gold, Bitcoin or DeFi: How can investors hedge against inflation?
Over the last 10 years, Bitcoin has been through 20 different bear markets. Is it finally starting to prove itself? Analysis Bitcoin (BTC) was created
Read more
Stroke contributing factors may include losing temper, extreme exercise: study
Losing one’s temper or exercising too rigorously could be contributing factors for a stroke, according to new research. In a study published Wednesday in the
Read more
US on the brink of default, think tank projects
The Bipartisan Policy Center (BPC) said on Friday the US federal government is likely to run out of borrowing room and breach the debt limit
Read more
Twitter labels American Heart Association link as ‘unsafe’ over Covid vaccines
Twitter is flagging an American Heart Association website link as ‘unsafe’ after the organization published an abstract of research linking Covid-19 vaccines to heart disease.
Read more
Fed’s Quarles says regulators should show ‘constraint’ on stablecoins to avoid hampering innovation
Quarles said some of the approaches on stablecoin regulation from the President’s Working Group on Financial Markets’ November report are unnecessary. News Speaking publicly for
Read more
Omicron variant in the US: What we know
The omicron COVID-19 variant is in the U.S. The White House and public health officials said Wednesday afternoon that the case was confirmed in a
Read more
Omicron detected in California, first case in the US, officials say
A traveler who returned to California from South Africa has become the first person in the United States identified to have the omicron variant of
Read more
FDA panel endorses first COVID-19 pill
A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of
Read more
Merck COVID-19 pill: FDA panel weighs safety, effectiveness
Government health advisers on Tuesday weighed the benefits and risks of a closely watched drug from Merck that could soon become the first U.S.-authorized pill
Read more